000250.KQ
Sam Chun Dang Pharm. Co., Ltd
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 155,400.00
−2.26%Margins
Gross margin
46.1%
EBITDA margin
13.1%
EBIT margin
6.8%
Net margin
6.8%
FCF margin
-16.5%
5.9%
Return on equity
3.1%
Return on assets
5.0%
Return on invested capital
0.45x
Asset turnover
KRW 26.1B
Cash from operations
KRW 6.8K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026